OptiNose Inc (OPTN)
1.29
+0.10
(+8.86%)
USD |
NASDAQ |
May 16, 16:00
1.11
-0.18
(-13.95%)
After-Hours: 05:20
OptiNose Cash from Operations (Quarterly): -22.02M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.02M |
| December 31, 2023 | 6.909M |
| September 30, 2023 | -4.425M |
| June 30, 2023 | -12.54M |
| March 31, 2023 | -10.48M |
| December 31, 2022 | -17.68M |
| September 30, 2022 | -17.50M |
| June 30, 2022 | -13.14M |
| March 31, 2022 | -19.34M |
| December 31, 2021 | -16.72M |
| September 30, 2021 | -9.701M |
| June 30, 2021 | -22.49M |
| March 31, 2021 | -28.02M |
| December 31, 2020 | -19.16M |
| September 30, 2020 | -15.53M |
| Date | Value |
|---|---|
| June 30, 2020 | -23.55M |
| March 31, 2020 | -27.97M |
| December 31, 2019 | -18.11M |
| September 30, 2019 | -15.13M |
| June 30, 2019 | -27.89M |
| March 31, 2019 | -29.69M |
| December 31, 2018 | -20.19M |
| September 30, 2018 | -24.13M |
| June 30, 2018 | -24.50M |
| March 31, 2018 | -23.00M |
| December 31, 2017 | -13.80M |
| September 30, 2017 | -8.244M |
| June 30, 2017 | -6.104M |
| March 31, 2017 | -7.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-28.02M
Minimum
Mar 2021
6.909M
Maximum
Dec 2023
-16.72M
Average
-17.59M
Median
Cash from Operations (Quarterly) Benchmarks
| Zevra Therapeutics Inc | -16.16M |
| Madrigal Pharmaceuticals Inc | -149.16M |
| Viking Therapeutics Inc | -6.134M |
| CytomX Therapeutics Inc | -26.04M |
| Spero Therapeutics Inc | -17.49M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.022M |
| Cash from Financing (Quarterly) | 0.007M |
| Free Cash Flow | -32.43M |
| Free Cash Flow Per Share (Quarterly) | -0.1958 |
| Free Cash Flow to Equity (Quarterly) | -22.47M |
| Free Cash Flow Yield | -22.39% |